Capital International, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Capital International, Inc.
- $7.23 Billion
- Q2 2024
A detailed history of Capital International, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International, Inc. holds 61,242 shares of REGN stock, worth $50.8 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
61,242
Previous 56,369
8.64%
Holding current value
$50.8 Million
Previous $54.3 Million
18.64%
% of portfolio
0.89%
Previous 0.76%
Shares
20 transactions
Others Institutions Holding REGN
# of Institutions
1,485Shares Held
85.7MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.46 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.01 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.87 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.02 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.85 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...